1. Significance of Understanding HBOC for At-Risk Relatives in Prostate and Pancreatic Cancer Patients Who Tested Positive on the Germline BRCA1/2 Genetic Testing in the Current Japanese Healthcare System
   Eriko Takamine, 2023, Practical Guide to Hereditary Breast and Ovarian Cancer CrossRef
2. DNA repair deficiency as circulating biomarker in prostate cancer
   Martina Catalano et al, 2023, Frontiers in Oncology CrossRef
3. Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer
   Fidelis Charles Bugoye et al, 2023, Frontiers in Genetics CrossRef
4. Effect of DNA Damage Response Mutations on Prostate Cancer Prognosis: A Systematic Review
   Stephanie L Swift et al, 2019, Future Oncology CrossRef
5. Minimally Invasive Urology in the Reiwa Era
   Jun Akatsuka et al, 2022, Nihon Ika Daigaku Igakkai Zasshi CrossRef
6. Case Report: Co-Existence of BRCA2 and PALB2 Germline Mutations in Familial Prostate Cancer With Solitary Lung Metastasis
   Tang Tang et al, 2020, Frontiers in Oncology CrossRef
7. PARP-remmers bij gemetastaseerde prostaatkanker: een systematische review
   K. Kortbeek et al, 2022, Tijdschrift voor Geneeskunde CrossRef
8. Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?
   Peter H. J. Slootbeek et al, 2024, Critical Reviews in Clinical Laboratory Sciences CrossRef
9. A Case-Based Clinical Approach to the Investigation, Management and Screening of Families with BRCA2 Related Prostate Cancer
   Bradley King et al, 2021, The Application of Clinical Genetics CrossRef
10. Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race
    Mehmet Bilen et al, 2024, ClinicoEconomics and Outcomes Research CrossRef
11. Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine
    Filippo Marino et al, 2023, Prostate Cancer and Prostatic Diseases CrossRef
12. Clinical significance of mutations in DNA repair genes in patients with metastatic prostate cancer
    O. A. Mailyan et al, 2021, Cancer Urology CrossRef
13. Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers
    Kanako Hagio et al, 2023, Cancer Science CrossRef
14. Risk Assessment and Prevention Strategies for Hereditary Gynecological Cancers
    Sayaka Ueno et al, 2022, Personalization in Gynecologic Oncology CrossRef